{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:10:37Z","timestamp":1762114237610,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"16-17","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"BFOS \u2014 Brugge"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.clinbiochem.2013.07.021","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T04:07:45Z","timestamp":1377576465000},"page":"1660-1663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris"],"prefix":"10.1016","volume":"46","author":[{"given":"Irena","family":"Korita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anyla","family":"Bulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel R.","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eline","family":"Verhoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Blaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0005","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1515\/cclm-2011-0636","article-title":"Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testing","volume":"50","author":"Langlois","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0010","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1373\/clinchem.2007.097360","article-title":"Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction","volume":"54","author":"Packard","year":"2008","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.clinbiochem.2013.07.021_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1373\/clinchem.2008.109728","article-title":"The clinical utility of high-sensitivity c-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines","volume":"55","author":"Mora","year":"2009","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.clinbiochem.2013.07.021_bb0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1373\/clinchem.2008.115923","article-title":"C-reactive protein and coronary heart disease: predictive test or therapeutic target?","volume":"55","author":"Hingorani","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0030","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1515\/CCLM.2009.037","article-title":"Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?","volume":"47","author":"Verhoye","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0155","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0045","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvn120","article-title":"Cytokines and atherosclerosis; a comprehensive review of studies in mice","volume":"79","author":"Kleeman","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways","volume":"86","author":"Tedgui","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1194\/jlr.R400017-JLR200","article-title":"Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?","volume":"46","author":"Chait","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cca.2006.01.031","article-title":"Historical milestones in measurement of HDL-cholesterol; Impact on clinical and laboratory practice","volume":"369","author":"Langlois","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0065","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/01.ATV.0000232522.47018.a6","article-title":"Understanding change in high density lipoproteins during the acute phase response","volume":"26","author":"Van Lenten","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.ATV.0000195789.39418.e8","article-title":"Assembly of high-density lipoprotein","volume":"26","author":"Yokoyama","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.atherosclerosis.2009.08.026","article-title":"Factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis","volume":"208","author":"Drexel","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0080","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1210\/jc.2011-1846","article-title":"LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals","volume":"97","author":"Haase","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0085","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"The Lancet"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0090","doi-asserted-by":"crossref","first-page":"722","DOI":"10.5551\/jat.3632","article-title":"Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels","volume":"17","author":"Horiuchi","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0095","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1479164109339966","article-title":"Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis","volume":"6","author":"Hu","year":"2009","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0100","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1161\/01.ATV.19.10.2355","article-title":"Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries","volume":"19","author":"Erren","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0160","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2796.2009.02120.x","article-title":"Serum amyloid A is independently associated with metabolic risk factors but not with early atherosclerosis: the Cardiovascular Risk in Young Finns Study","author":"Jylh\u00e4v\u00e4","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0110","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.jacc.2005.06.080","article-title":"High-density lipoprotein function: recent advances","volume":"46","author":"Ansell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/ATVBAHA.108.178681","article-title":"HDL remodeling during the acute phase response","volume":"29","author":"Jahangiri","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/cvr\/cvs089","article-title":"High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A","volume":"94","author":"T\u00f6lle","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbalip.2011.07.013","article-title":"The HDL proteome in acute coronary syndromes shifts to an inflammatory profile","volume":"1821","author":"Alwaili","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0130","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1194\/jlr.M017681","article-title":"Nascent HDL formation by hepatocytes is reduced by the concerted action of serum amyloid A and endothelial lipase","volume":"52","author":"Wroblewski","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0135","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/01.ATV.0000205595.19612.c9","article-title":"Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis","volume":"26","author":"Klerkx","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0140","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/01.ATV.0000227472.70734.ad","article-title":"Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes","volume":"26","author":"Chang","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinbiochem.2013.07.021_bb0145","doi-asserted-by":"crossref","first-page":"e34031","DOI":"10.1371\/journal.pone.0034031","article-title":"The acute phase protein serum amyloid A induces lipolysis and inflammation in human adipocytes through distinct pathways","volume":"7","author":"Faty","year":"2012","journal-title":"PLoS One"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201300355X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201300355X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:08:46Z","timestamp":1762114126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991201300355X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":29,"journal-issue":{"issue":"16-17","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S000991201300355X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.07.021","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}